Search results for "WTH"

showing 10 items of 5145 documents

Glucose Metabolism in Children With Growth Hormone Deficiency

2018

Background: The growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis has a fundamental impact on glucose metabolism. Therefore, both untreated GH deficiency (GHD) and GH treatment (GHT) may be associated with some metabolic alterations, although the abnormalities of glucose metabolism have been investigated by relatively few studies as main outcomes. Aim: The present review summarizes the available data on glucose metabolism in children with GHD, providing an overview of the current state of the art in order better to clarify the real metabolic impact of GHD and GHT. Methods: Among all the existing studies, we evaluated all original studies that fulfilled our criteria for analysis …

medicine.medical_specialtyChildren; Glucose; Growth hormone; Insulin sensitivity; Metabolism; Endocrinology Diabetes and MetabolismEndocrinology Diabetes and MetabolismMini Review030209 endocrinology & metabolismCarbohydrate metabolismGrowth hormonelcsh:Diseases of the endocrine glands. Clinical endocrinologyReporting parametersGrowth hormone deficiencySettore MED/13 - EndocrinologiaFasting glucose03 medical and health sciences0302 clinical medicineInsulin resistanceEndocrinologychildrenInternal medicinemedicineGlucose homeostasisinsulin sensitivityglucoselcsh:RC648-665business.industryMetabolismmedicine.diseaseEndocrinology030220 oncology & carcinogenesisgrowth hormonebusinessmetabolismFrontiers in Endocrinology
researchProduct

Getting the Fat out of Met and Fas

2008

Lack of Fas antagonism by Met in human fatty liver disease. Zou C, Ma J, Wang X, Guo L, Zhu Z, Stoops J, Eaker AE, Johnson CJ, Strom S, Michalopoulos GK, DeFrances MC, Zarnegar R. Hepatocytes in fatty livers are hypersensitive to apoptosis and undergo escalated apoptotic activity via death receptor-mediated pathways, particularly that of Fas–FasL, causing hepatic injury that can eventually proceed to cirrhosis and end-stage liver disease. Here we report that the hepatocyte growth factor receptor, Met, plays an important part in preventing Fas-mediated apoptosis of hepatocytes by sequestering Fas. We also show that Fas antagonism by Met is abrogated in human fatty liver disease (FLD). Throug…

medicine.medical_specialtyCirrhosisHepatologyFatty liverBiologymedicine.diseaseMolecular biologyFas ligandLiver diseaseEndocrinologyHepatocyte Growth Factor ReceptorApoptosisInternal medicinemedicineExtracellularAntagonismJournal of Hepatology
researchProduct

Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe

2018

Abstract: Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely silent pandemic, its elimination is made possible through the availability of the new antiviral drugs and the implementation of prevention practices. On 17 February 2016, the Hepatitis B & C Public Policy Association held the first EU HCV Policy Summit in Brussels. This summit was an historic event as it was the first high-level conference focusing on the elimination of HCV at the European Union level. The …

medicine.medical_specialtyCivil societyEconomic growthMedizinPublic policyHepacivirusAntiviral AgentsPatient advocacy03 medical and health sciences0302 clinical medicineVirologyPolitical sciencePandemicPrevalencemedicineHumansmedia_common.cataloged_instanceEuropean Union030212 general & internal medicineDisease EradicationEuropean unionmedia_commongeographySummitgeography.geographical_feature_categoryHepatologyPublic healthmedicine.diseaseHepatitis CEuropeInfectious DiseasesHCVEpidemiological Monitoring030211 gastroenterology & hepatologyHuman medicineViral hepatitisJournal of Viral Hepatitis
researchProduct

Genetic basis of dental agenesis - molecular genetics patterning clinical dentistry

2013

Tooth agenesis is one of the most common congenital malformations in humans. Hypodontia can either occur as an isolated condition (non-syndromic hypodontia) or can be associated with a syndrome (syndromic hypodontia), highlighting the heterogeneity of the condition. Though much progress has been made to identify the developmental basis of tooth formation, knowledge of the etiological basis of inherited tooth loss is still lacking. To date, the mutation spectra of non-syndromic form of familial and sporadic tooth agenesis in humans have revealed defects in various such genes that encode transcription factors, MSX1 and PAX9 or genes that code for a protein involved in canonical Wnt signaling …

medicine.medical_specialtyDentistryOdontologíaReviewBiologyAnodontiaMolecular geneticsAXIN2medicineTooth lossHumansMolecular BiologyGeneral DentistryAnodontiaGeneticsOral Medicine and Pathologybusiness.industryFibroblast growth factor receptor 1Wnt signaling pathwaySyndrome:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludstomatognathic diseasesHypodontiaOtorhinolaryngologyDentistryUNESCO::CIENCIAS MÉDICASOdontogenesisSurgerymedicine.symptombusinessPAX9Medicina Oral Patología Oral y Cirugia Bucal
researchProduct

Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy : A systematic review and meta-analysis

2017

Background/aim: Deficiency of acetyl-L-carnitine (ALC) and L-carnitine (LC) appears to play a role in peripheral diabetic neuropathy, although the evidence in humans is still limited. We conducted a systematic review and meta-analysis investigating the effect of ALC on pain and electromyographic parameters in people with diabetic neuropathy. Methods: A literature search in major databases, without language restriction, was undertaken. Eligible studies were randomized controlled trials (RCTs) or pre-and post-test studies. The effect of ALC supplementation on pain perception and electromyographic parameters in patients with diabetic neuropathy was compared vs. a control group (RCTs). The effe…

medicine.medical_specialtyDiabetic neuropathyDiabetePlaceboNerve conduction velocitylaw.inventionRATS03 medical and health sciencesGLUTAMATE0302 clinical medicineRandomized controlled triallawDiabetes mellitusMedicineQUALITYMeta-analysi030212 general & internal medicineUlnar nerveAdverse effectbusiness.industryDiabetesNERVE GROWTH-FACTORPAINmedicine.diseaseAcetyl-L-carnitine3. Good healthSurgeryNeuropathyAcetyl-L-carnitine; Diabetes; Meta-analysis; Neuropathy; Gerontology; Geriatrics and GerontologyMeta-analysisPeripheral neuropathyAnesthesia3121 General medicine internal medicine and other clinical medicineGeriatrics and GerontologybusinessGerontology030217 neurology & neurosurgeryCLINICAL-TRIALS
researchProduct

Body mass reduction markedly improves muscle performance and body composition in obese females aged 61-75 years: comparison between the effects exert…

2004

OBJECTIVE: To investigate the effectiveness of a body mass reduction programme entailing diet caloric restriction and moderate physical activity with or without supplementary treatment with recombinant (r) GH or steroids to improve body composition and muscle performance in severely obese women aged 61-75 years. METHODS: Twenty women were randomly assigned to one of three groups: body mass reduction alone; body mass reduction plus rGH; body mass reduction plus nandrolone undecanoate. Body composition, isotonic muscle strength and anaerobic power output during jumping were determined before and after the 3-week period. RESULTS: Whatever the experimental group considered, body mass (P<0.01…

medicine.medical_specialtyDoseStrength trainingEndocrinology Diabetes and Metabolismmedicine.disease_causeBody Mass IndexEndocrinologyJumpingInternal medicinemedicineHumansNandroloneTestosteroneIsotonic ContractionObesityInsulin-Like Growth Factor IExerciseAgedNandrolone undecanoatebusiness.industryGeneral MedicineLuteinizing HormoneMiddle Agedmedicine.diseaseCombined Modality TherapyObesityEndocrinologyNandroloneGrowth HormoneBody CompositionFemaleFollicle Stimulating HormonebusinessBody mass indexAnaerobic exercisemedicine.drugEuropean Journal of Endocrinology
researchProduct

The ecdysone-induced DHR4 orphan nuclear receptor coordinates growth and maturation in Drosophila

2005

0092-8674 (Print) Journal Article Research Support, Non-U.S. Gov't; A critical determinant of insect body size is the time at which the larva stops feeding and initiates wandering in preparation for metamorphosis. No genes have been identified that regulate growth by contributing to this key developmental decision to terminate feeding. We show here that mutations in the DHR4 orphan nuclear receptor result in larvae that precociously leave the food to form premature prepupae, resulting in abbreviated larval development that translates directly into smaller and lighter animals. In addition, we show that DHR4 plays a central role in the genetic cascades triggered by the steroid hormone ecdyson…

medicine.medical_specialtyEcdysonemedicine.medical_treatmentmedia_common.quotation_subjectRepressorReceptors Cytoplasmic and NuclearBiologymedicine.disease_causeGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundInternal medicineReceptorsmedicineDrosophila ProteinsAnimalsMetamorphosisDrosophila/genetics/*growth & developmentPupa/physiologyRegulator genemedia_commonLarvaMutationMetamorphosisBiochemistry Genetics and Molecular Biology(all)Biological/physiologyfungiMetamorphosis BiologicalPupaGene Expression Regulation DevelopmentalDrosophila Proteins/genetics/*metabolismDevelopmental/physiologyCytoplasmic and Nuclear/genetics/*metabolismNeurosecretory SystemsCell biologyEcdysone/*metabolismSteroid hormoneEndocrinologyNuclear receptorchemistryGene Expression RegulationLarvaLarva/growth & developmentMutationNeurosecretory Systems/metabolismDrosophilaEcdysone
researchProduct

Quo vadis SANEPID? A cross-country analysis of public health reforms in 10 post-Soviet states

2010

Abstract Background The public health systems of the post-Soviet states have evolved from the san-epid system, which dominated public health practice throughout the former Soviet Union. Since independence, reforms have taken different directions. This article provides a cross-country comparison of public health reform processes and contents in 10 post-Soviet states. Methods The study is descriptive and comparative, based on a literature review of the major health databases, the Health Systems in Transition (HiT) volumes and grey literature. Search terms included terms on public health, the san-epid services and organizational reforms in one or several post-Soviet states. Results Public heal…

medicine.medical_specialtyEconomic growthAzerbaijanRepublic of BelarusHealth PromotionPublic administrationGeorgia (Republic)medicineHumansPost-Soviet statesKyrgyzstanHealth policybusiness.industryHealth PolicyPublic healthInternational healthUzbekistanGrey literatureArmeniaMoldovaKazakhstanSiberiaHealth promotionHealth Care ReformPreventive MedicineIntersectoral CollaborationUkrainebusinessPublic Health AdministrationStrengths and weaknessesHealth Policy
researchProduct

Health indicators as indicators of the progress of civilization

2018

medicine.medical_specialtyEconomic growthCivilizationPolitical sciencemedia_common.quotation_subjectPublic healthmedicinePopulation healthHealth indicatormedia_commonZdrowie Publiczne i Zarządzanie
researchProduct

Rare diseases and orphan drugs: Latvian story

2014

Background Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in the public health system, though there are significant differences in the national healthcare services for rare diseases among the EU States. This study aims to determine situation in the field of rare diseases in Latvia and compare it with other European countries. Methods We used the national plan for rare diseases, EUCERD reports, Orphanet data, Latvian and European regulations, publicly availa…

medicine.medical_specialtyEconomic growthNational Health ProgramsOrphan Drug ProductionLegislationReviewPharmacologyOrphan drugRare DiseasesPolitical scienceOrphan Drug ProductionHealth caremedicineMember stateHumansOrphan drugsGenetics(clinical)Pharmacology (medical)Genetics (clinical)Medicine(all)business.industryPublic healthLatvianAvailabilityLegislatureGeneral MedicineLegislation DrugAccessibilityLatvialanguage.human_languageEuropelanguagebusinessOrphanet Journal of Rare Diseases
researchProduct